Bruker Corp (BRKR)
56.66
+0.44
(+0.79%)
USD |
NASDAQ |
Nov 22, 13:04
Bruker Total Liabilities (Quarterly): 4.270B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 4.270B |
June 30, 2024 | 4.078B |
March 31, 2024 | 3.056B |
December 31, 2023 | 2.837B |
September 30, 2023 | 2.575B |
June 30, 2023 | 2.606B |
March 31, 2023 | 2.565B |
December 31, 2022 | 2.48B |
September 30, 2022 | 2.383B |
June 30, 2022 | 2.394B |
March 31, 2022 | 2.513B |
December 31, 2021 | 2.565B |
September 30, 2021 | 2.038B |
June 30, 2021 | 2.071B |
March 31, 2021 | 2.053B |
December 31, 2020 | 2.075B |
September 30, 2020 | 1.917B |
June 30, 2020 | 2.037B |
March 31, 2020 | 2.037B |
December 31, 2019 | 1.833B |
September 30, 2019 | 1.497B |
June 30, 2019 | 1.480B |
March 31, 2019 | 1.321B |
December 31, 2018 | 1.201B |
September 30, 2018 | 1.064B |
Date | Value |
---|---|
June 30, 2018 | 1.021B |
March 31, 2018 | 1.040B |
December 31, 2017 | 1.215B |
September 30, 2017 | 1.222B |
June 30, 2017 | 1.150B |
March 31, 2017 | 1.108B |
December 31, 2016 | 1.115B |
September 30, 2016 | 1.097B |
June 30, 2016 | 1.050B |
March 31, 2016 | 1.031B |
December 31, 2015 | 997.10M |
September 30, 2015 | 1.075B |
June 30, 2015 | 1.053B |
March 31, 2015 | 1.051B |
December 31, 2014 | 1.093B |
September 30, 2014 | 1.098B |
June 30, 2014 | 1.118B |
March 31, 2014 | 1.159B |
December 31, 2013 | 1.138B |
September 30, 2013 | 1.156B |
June 30, 2013 | 1.079B |
March 31, 2013 | 1.119B |
December 31, 2012 | 1.147B |
September 30, 2012 | 1.104B |
June 30, 2012 | 1.108B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.833B
Minimum
Dec 2019
4.270B
Maximum
Sep 2024
2.519B
Average
2.437B
Median
Total Liabilities (Quarterly) Benchmarks
Azenta Inc | 331.07M |
Harvard Bioscience Inc | 65.92M |
Bionano Genomics Inc | 38.49M |
Akoya Biosciences Inc | 116.34M |
Singular Genomics Systems Inc | 63.30M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.113B |
Shareholders Equity (Quarterly) | 1.807B |
Debt to Equity Ratio | 1.271 |
Current Ratio | 1.658 |
Net Debt Paydown Yield | -2.01% |